Based on this, the purpose of this study was to determine whether EV-derived MARCKSL1 can distinguish metastatic colorectal and nonmetastatic colorectal cancer and whether it can be used as an early diagnostic biomarker of metastatic colorectal cancer. This evidence concerns the gene MARCKSL1 and metastatic colorectal cancer.